Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide + dexamethasone pilot study in untreated primary plasma cell leukemia
2008-003246-28Phase 2Active
- Sponsor
- IRCCS CROB
- Start
- Jul 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lenalidomide and dexamethasone in plasma cell leukaemia (PCL), sponsored by IRCCS CROB. Primary endpoint: Response rate. Started Jul 2008; status: active.
02
Drugs
lenalidomidedexamethasone
03
Conditions
plasma cell leukaemia (PCL)
Beyond the preview
Go deeper on 2008-003246-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003246-28.